4.7 Article

Antiviral activity of glycoprotein GP-1 isolated from Streptomyces kanasensis ZX01

Journal

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.ijbiomac.2016.04.038

Keywords

Glycoprotein GP-1; Induced systemic resistance; Tobacco mosaic virus

Funding

  1. National Key Technology R&D Program of China [2014BAD23B01]
  2. National Natural Science Foundation of China (NSFC) [31201536]
  3. Fundamental Research Funds for the Central Universities of China [2452015010]

Ask authors/readers for more resources

Plant virus diseases have seriously damaged global food security. However, current antiviral agents are not efficient enough for the requirement of agriculture production. So, developing new efficient and nontoxic antiviral agents is imperative. GP-1, from Streptomyces kanasensis ZX01, is a new antiviral glycoprotein, of which the antiviral activity and the mode of action against Tobacco mosaic virus (TMV) were investigated in this study. The results showed that GP-1 could fracture TMV particles, and the infection and accumulation of TMV in host plants were inhibited. Moreover, GP-1 could induce systematic resistance against TMV in the host, according to the results of activities of defensive enzymes increasing, MDA decreasing and overexpression of pathogenesis-related proteins. Furthermore, GP-1 could promote growth of the host plant. In conclusion, GP-1 showed the ability to be developed as an efficient antiviral agent and a fertilizer for agriculture. (C) 2016 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available